Amy E. Moran

ORCID: 0000-0003-1952-7737

Publishes on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Prostate Cancer Treatment and Research. 168 papers and 4.3k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

168Publications

4.3kTotal Citations

First publication: 1993First senior author: 2018

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Prostate Cancer Treatment and Research Immune Cell Function and Interaction CAR-T cell therapy research

Top publicationsby citations

T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse

Amy E. Moran, Kristin A. Hogquist|The Journal of Experimental Medicine|2011

Cited by 1k

Androgen receptor activity in T cells limits checkpoint blockade efficacy

Xiangnan Guan, Amy E. Moran|Nature|2022

Cited by 385

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

Julie N. Graff, Amy E. Moran|Journal for ImmunoTherapy of Cancer|2020

Cited by 120

Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice

Amy E. Moran, Monica M. Bertagnolli|Journal of Biological Chemistry|2004

Cited by 111

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Lisa N. Chesner, Amy E. Moran|Cancer Discovery|2024

Cited by 40